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1775 Remote control of pulmonary blood flow: Initial clinical experience
Antonio F. Corno, MD, FRCS, FETCS, Damien Bonnet, MD, Nicole Sekarski, MD, FACP,
Daniel Sidi, MD, Pascal Vouhe´, MD, FECTS, and Ludwig K. von Segesser, MD, FACS, FETCS,
Lausanne, Switzerland, and Paris, France
Six patients underwent PAB with the FloWatch-R-PAB, an implantable device with telemetric
control. In a 7-month mean follow-up, a mean of 5 regulations per patient was required to
adjust the PAB, without deaths, reoperations, or device-related complications. In children
requiring PAB, the therapeutic strategies can be expanded by this promising technology.
1781 Improved early outcome for end-stage dilated cardiomyopathy in children
Anne-Marie McMahon, MRCPCH, Carin van Doorn, FRCS (C/Th), Michael Burch, FRCP,
Pauline Whitmore, RSCN, Sophie Neligan, RSCN, Philip Rees, FRCP, Rosemary Radley-Smith,
FRCP, Allan Goldman, FRCPCH, Katherine Brown, MRCP, Gordon Cohen, MD,
Victor Tsang, FRCS, and Martin Elliott, MD, FRCS, London, United Kingdom
Mechanical cardiac assistance, high priority listing, and ABO incompatible transplantation have
improved the early outcome of children with end-stage dilated cardiomyopathy.
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1788 Surgery for atrial fibrillation using radiofrequency catheter ablation
Bruno Chiappini, MD, Sofia Martı`n-Sua`rez, MD, Antonino LoForte, MD,
Roberto Di Bartolomeo, MD, and Giuseppe Marinelli, MD, Bologna, Italy
We describe our experience in the surgical treatment of atrial fibrillation using radiofrequency
catheter ablation in 40 patients (8 men and 32 women) undergoing cardiac surgery. Of the 40
patients, 88.5% recovered sinus rhythm after a mean follow-up time of 16.5  2.5 months.
1792 Surgery modifies cardiac sensory transduction
Mathias Waldmann, MD, Robert P-C. Chen, MD, and J. Andrew Armour, MD, PhD, Montreal,
Quebec, Canada; Aachen, Germany; and Halifax, Nova Scotia, Canada
The capacity of cardiac afferent neurons to transduce the cardiac milieu is obtunded by surgery
involving their myocardial sensory fields. Remodeling of cardiac sensory transduction
presumably has negative implications with respect to how the entire cardiac neuronal hierarchy
responds to the postsurgical cardiac milieu.
1798 Comparative efficacies and durations of action of phenoxybenzamine,
verapamil/nitroglycerin solution, and papaverine as topical antispasmodics
for radial artery coronary bypass grafting
Shafi Mussa, MA, MRCS, Tomasz J. Guzik, MD, PhD, Edward Black, FRCS, Michelle A. Dipp,
DPhil, Keith M. Channon, MD, MRCP, and David P. Taggart, MD, PhD, FRCS, Oxford,
United Kingdom
Isometric tension studies of human radial arteries comparing the topical antispasmodics
phenoxybenzamine, verapamil/nitroglycerin solution, and papaverine demonstrate that
phenoxybenzamine specifically prevents catecholamine-mediated spasm for a prolonged period,
verapamil/nitroglycerin solution has a broader range of action that lasts less than 5 hours, and
papaverine has limited action and duration.
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